Bryan Innis

Bryan Innis has a diverse work experience in the fields of healthcare, research, and consulting. Bryan is currently working as an Associate Director of Global Market Access and HEOR at Sarepta Therapeutics since May 2022. Prior to that, from May 2021 to May 2022, they worked as a Consultant in Life Science Strategy at IQVIA. Before joining IQVIA, Bryan was an Independent Consultant from March 2019 to August 2020, focusing on generating evidence for regulatory filings and commercial activities in areas such as Vaccines/Immunology and Rare Disease/Neurology. Bryan also worked as a Teaching Assistant at the University of Southern California's School of Pharmacy from August 2018 to July 2020. Earlier in their career, Bryan had internships at Amgen and Partners HealthCare, and held positions at Biogen, The Barque Group, Progenika Inc, and the Broad Institute. Their roles ranged from Project Manager and Research Associate to Business Analyst and Research Associate in various research and development capacities.

Bryan Innis has a Bachelor of Science (BS) degree in Biology from Boston College, which they obtained from 2003 to 2007. Bryan then attended the Harvard Extension School from 2007 to 2008, although no degree or field of study information is available for this period. Bryan then pursued a Master of Science (MS) degree in Pharmaceutical Economics and Policy at the University of Southern California from 2016 to 2018. Currently, they are a PhD student at the University of Southern California, specializing in Health Economics & Policy, starting in 2018 and expected to complete in 2020.